Corey Davis

Stock Analyst at HC Wainwright & Co.

(3.00)
# 1,508
Out of 5,045 analysts
17
Total ratings
75%
Success rate
25.83%
Average return

Stocks Rated by Corey Davis

Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $480$390
Current: $59.63
Upside: +554.03%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.69
Upside: +7,179.08%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560$40
Current: $21.07
Upside: +89.84%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $2.69
Upside: +6,219.70%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $5.41
Upside: +269.69%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $21.01
Upside: +137.98%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $135.73
Upside: +6.09%